Treatment of panic disorder with agoraphobia: Comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone

American Journal of Psychiatry

Volumn 152, Issue 5, 1995, Pages 683-691

  De Beurs, Edwin ^b   Van Balkom, Anton J L M ^b   Lange, Alfred ^b   Koele, Pieter ^b   Van Dyck, Richard ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUVOXAMINE;

ADULT; AGORAPHOBIA; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PANIC; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL;

EID: 0028952254     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.152.5.683     Document Type: Article

References (63)

1. Trull TJ, Nietzel MT, Main A: The use of meta-analysis to assess the clinical significance of behavior therapy for agoraphobia. Behavior Therapy 1988; 19:527-538
2. Jacobson NS, Wilson L, Tupper C: The clinical significance of treatment gains resulting from exposure-based interventions for agoraphobia: a reanalysis of outcome data. Behavior Therapy 1988; 19:539-554
3. Barlow DH, Craske MG: The phenomenology of panic, in Panic: Psychological Perspectives. Edited by Rachman S, Maser JD. Hillsdale, NJ, Lawrence Erlbaum Associates, 1988
4. Klerman GL: Treatments for panic disorder. J Clin Psychiatry 1992; 53(March suppl):14-19
5. Zitrin ZM, Klein DF, Woerner MG, Ross DC: Treatment of phobias, I: comparison of imipramine hydrochloride and placebo. Arch Gen Psychiatry 1983; 40:125-138
6. Mavissakalian M, Michelson L: Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine. J Clin Psychiatry 1986; 47:117-122
7. Kahn RS, Westenberg HG, Verhoeven WM: Effect of a serotonin precursor and uptake inhibitor in anxiety disorders: a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. Int Clin Psychopharmacol 1987; 2:33-45
8. Johnston DG, Troyer IF, Whitsett SF: Clomipramine treatment of agoraphobic women: an eight week controlled trial. Arch Gen Psychiatry 1988; 45:435-439
9. Sheehan DV, Ballenger JC, Jacobsen G: Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. Arch Gen Psychiatry 1980; 37:51-59
10. den Boer JA, Westenberg HGM, Kamerbeek WDJ: Effect of a serotonin uptake inhibitor in anxiety disorders: a double-blind comparison of clomipramine and fluvoxamine. Int Clin Psychopharmacol 1987; 2:21-32
11. den Boer JA, Westenberg HGM: Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder: a double-blind comparative study with fluvoxamine and maprotiline. Int Clin Psychopharmacol 1988; 3:59-74
12. Ballenger JC, Burrows G, DuPont RL Jr, Lesser IM, Noyes R Jr, Pecknold JC, Rifkin A, Swinson RP: Alprazolam in panic disorder and agoraphobia: results from a multicenter trial, 1: efficacy in short-term treatment. Arch Gen Psychiatry 1988; 45: 413-422
13. Cross-National Collaborative Panic Study Second Phase Investigators: Drug treatment of panic disorder: comparative efficacy of alprazolam, imipramine, and placebo. Br J Psychiatry 1992; 160:191-202; correction, 161:724
14. Clark DM: Cognitive therapy for anxiety. Behavioral Psychotherapy 1986; 14:283-294
15. Sokol L, Beck AT, Greenberg RL, Wright FD, Berchick RJ: Cognitive therapy of panic disorder: a nonpharmacological alternative. J Nerv Ment Dis 1989; 177:711-716
16. Ost LG: Applied relaxation versus progressive relaxation in the treatment of panic disorder. Behav Res Ther 1988; 26:13-22
17. Barlow DH, Cerny JA: Psychological Treatment of Panic. New York, Guilford Press, 1988
18. Clark DM, Salkovskis PM, Chalkley AJ: Respiratory control as a treatment for panic attacks. J Behav Ther Exp Psychiatry 1985; 16:23-30
19. Bonn JA, Redhead CPA, Timmons BH: Enhanced adaptive behavioural response in agoraphobic patients with breathing retraining. Lancet 1984; 2:665-669
20. Ley R: Panic disorder and agoraphobia: fear of fear or the symptoms produced by hyperventilation? J Behav Ther Exp Psychiatry 1987; 18:305-316
21. Clum GA: Psychological interventions vs drugs in the treatment of panic. Behavior Therapy 1989; 20:429-457
22. Mattick RP, Andrews G, Hadzi-Pavlovic D, Christensen H: Treatment of panic and agoraphobia: an integrative review. J Nerv Ment Dis 1990; 178:567-576
23. McNally RJ: Psychological approaches to panic disorder: a review. Psychol Bull 1990; 108:403-419
24. Michelson LK, Marchione K: Behavioral, cognitive, and pharmacological treatments of panic disorder with agoraphobia: critique and synthesis. J Consult Clin Psychol 1991; 59:100-114
25. Black DW, Wesner R, Bowers W, Gabel J: A comparison of fluvoxamine, cognitive therapy and placebo in the treatment of panic disorder. Arch Gen Psychiatry 1993; 50:44-50
26. 2. Br J Psychiatry 1986; 148:526-532
27. Hibbert GA, Chan M: Respiratory control: its contribution to the treatment of panic attacks: a controlled study. Br J Psychiatry 1989; 154:232-236
28. Marks IM, Mathews AM: Brief standard self-rating for phobic patients. Behav Res Ther 1979; 17:263-267
29. Wardle J: Behaviour therapy and benzodiazepines: allies or antagonists? Br J Psychiatry 1990; 156:163-168
30. Clark DB, Taylor CB, Roth WT, Hayward C, Ehlers A, Margraf J, Agras WS: Surreptitious drug use by patients in a panic disorder study. Am J Psychiatry 1990; 147:507-509
31. Di Nardo PA, O'Brien GT, Barlow DH, Waddell MT, Blanchard EB: Reliability of DSM-III anxiety disorder categories using a new structured interview. Arch Gen Psychiatry 1983; 40:1070-1075
32. Ascher LM, Schotte DE, Grayson JB: Enhancing effectiveness of paradoxical intention in treating travel restriction in agoraphobia. Behavior Therapy 1986; 17:124-130
33. Lange A, de Beurs E: Multidimensional family treatment of agoraphobia. J Family Psychotherapy 1992; 3:45-72
34. Emmelkamp PMG: Phobic and Obsessive-Compulsive Disorders: Theory, Research, and Practice. New York, Plenum, 1982
35. Chambless DL, Caputo GC, Jasin SE, Gracely EJ, Williams C: The Mobility Inventory for Agoraphobia. Behav Res Ther 1985; 23:35-44
36. Chambless DL, Caputo GC, Bright P, Gallagher R: Assessment of fear of fear in agoraphobics: the Body Sensations Questionnaire and the Agoraphobic Cognitions Questionnaire. J Consult Clin Psychol 1984; 52:1090-1097
37. Derogatis LR: SCL-90-R: Administration, Scoring, and Procedures Manual, I, for the Revised Version. Baltimore, Johns Hopkins University, Clinical Psychometrics Research Unit, 1977
38. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-571
39. van Rooijen L, Arrindell WA: Depressiegevoelens bij psychiatrische patienten en hun partners: betrouwbaarheid en validiteit van de VROPSOM-lijsten (Depressive moods of psychiatric outpatients and their spouses: reliability and validity of the VROPSOM-lists). Gedrag & Gezondheid 1987; 15:65-73
40. Rushton JP, Brainerd CJ, Pressley M: Behavioral development and construct validity: the principle of aggregation. Psychol Bull 1983; 94:18-38
41. de Beurs E: The Assessment and Treatment of Panic Disorder and Agoraphobia. Amsterdam, Thesis Publishers, 1993
42. de Beurs E, Lange A, Van Dyck R, Blonk RWB, Koele P: Behavioral assessment of avoidance in agoraphobia. J Psychopathology and Behavioral Assessment 1991; 13:285-300
43. de Beurs E, Lange A, Koele P, Van Dyck R: Frequency of panic as an outcome measure in agoraphobia research: latent effects of exposure on panic. J Anxiety Disorders 1993; 7:307-319
44. Kiresuk TJ, Sherman RE: Goal attainment scaling: a general method for evaluating comprehensive community mental health programs. Community Ment Health J 1968; 4:443-453
45. de Beurs E, Lange A, Blonk RWB, Koele P, van Balkom AJLM, Van Dyck R: Goal attainment scaling: an idiosyncratic method to assess treatment effectiveness in agoraphobia. J Psychopathology and Behavioral Assessment 1993; 15:357-373
46. Newman FL: Therapist's evaluation of psychotherapy, in The Assessment of Psychotherapy Outcome. Edited by Lambert MJ, Christensen ER, Dejulio SS. New York, John Wiley & Sons, 1983
47. Fawcett S: Symptoms, signs, side effects checklist. Psychopharmacol Bull 1987; 23:322-323
48. Tabachnick BG, Fidell LS: Using Multivariate Statistics. New York, HarperCollins, 1989
49. Crowder MJ, Hand DJ: Analysis of Repeated Measures: Monographs on Statistics and Applied Probability. London, Chapman and Hall, 1990
50. Lelliott P, McNamee G, Marks I: Features of agora-, social, and related phobias and validation of the diagnoses. J Anxiety Disorders 1991; 5:313-322
51. Chambless DL: The relationship of severity of agoraphobia to associated psychopathology. Behav Res Ther 1985; 23:305-310
52. Marks IM, Swinson RP, Basoglu M, Kuch K, Noshirvani H, O'Sullivan G, Lelliott PT, Kirby M, McNamee G, Sengun S, Wickwire K: Alprazolam and exposure alone and combined in panic disorder with agoraphobia: a controlled study in London and Toronto. Br J Psychiatry 1993; 162:776-787
53. Hurst HE, Jones DR, Jarboe CH, De Bree H: Determination of clovoxamine concentration in human plasma by electron gas chromatography. Clin Chem 1981; 27:1210-1212
54. Oxtoby A, Jones A, Robinson M: Is your "double-blind" design truly double-blind? Br J Psychiatry 1989; 155:700-701
55. White K, Kando J, Park T, Waternaux C, Brown WA: Side effects and the "blindability" of clinical drug trials. Am J Psychiatry 1992; 149:1730-1731
56. Hunter JE, Schmidt FL: Methods of Meta-Analysis: Correcting Error and Bias in Research Findings. Newbury Park, Calif, Sage, 1990, pp 348, 382
57. Klosko JS, Barlow DH, Tassinari R, Cerny JA: A comparison of alprazolam and behavior therapy in treatment of panic disorder. J Consult Clin Psychol 1990; 58:77-84
58. Garssen B, de Ruiter C, Van Dyck R: Breathing retraining: a rational placebo? Clin Psychol Rev 1992; 12:141-154
59. de Ruiter C, Rijken H, Garssen B, Kraaimaat F: Breathing retraining, exposure and a combination of both, in the treatment of panic disorder with agoraphobia. Behav Res Ther 1989; 27: 647-655
60. Korrelboom CW, Kernkamp JHB, Hoogduin CAL, Severeijns R: Paniekmanagement en het voorspellen van outcome bij agorafobie (Panic management training and the prediction of outcome in agoraphobia: a study in therapy outcome). Gedragstherapie 1992; 25:183-200
61. Salkovskis PM, Clark DM, Hackmann A: Treatment of panic attacks using cognitive therapy without exposure or breathing retraining. Behav Res Ther 1991; 29:161-166
62. Shear MK, Pilkonis PA, Cloitre M, Leon AC: Cognitive behavioral treatment compared with nonprescriptive treatment of panic disorder. Arch Gen Psychiatry 1994; 51:395-401
63. Shear MK, Maser JD: Standardized assessment for panic disorder research: a conference report. Arch Gen Psychiatry 1994; 51:346-354